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Background
Contact allergy is present in 58-67% children with
chronic eczema, yet some children with contact allergy
never develop eczema. To assess the significance of con-
tact allergy in eczema, rates of sensitization to each hap-
ten should be compared between eczema patients and
general ("healthy”) population. It seems reasonable that
haptens with higher odds ratios and attributed risk for
sensitization (i.e. better discriminating between ill and
healthy) are “more important” in eczema, whether cause
or result. The present study was aimed at estimating
these indices for selected haptens.
Method
A systematic review of published data on the prevalence
of sensitization to various haptens in eczema patients
and the general population of children. The data were
extracted and pooled to calculate estimated odds ratios
(eOD) and estimated attributable risks (eAR).
Results
Preliminary analysis has shown that these indices differ
substantially for various haptens. The highest eOD was
found for formaldehyde: its value of 31.3 means that con-
tact sensitization to this hapten was 31.3 times more fre-
quent in children with eczema than in healthy ones. As
9.4% children with eczema and only 0.3% healthy children
were sensitized to formaldehyde, the computed eAR for
this hapten amounted to 9.1%. Other analysed haptens
were Myroxylon pereirae (Balsam of Peru, eOD=21.6;
eAR=10.3%), wool alcohols (lanolin, eOD=17.3;
eAR=11.4%), MI/MCI (Kathon CG,
eOD=15.0; eAR=19.6%), chromium (eOD=8.3;
eAR=10.9%), fragrance mix (eOD=6.9; eAR=10.1%),
nickel (eOD=2.3; eAR=10.9%), PTBF resin (eOD=1.4;
eAR=0.4%) and neomycin (eOD=0.9; eAR=-0.3), to
name just a few examples.
Conclusion
Sensitization rates to certain haptens are considerably
higher among children with eczema than in healthy chil-
dren, while there is no difference for others. The pro-
posed approach offers a valuable insight into significance
of particular haptens and may help at selecting haptens
for routine patch testing in children with eczema.
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